• The interaction of macrophage and non-macrophage tropic isolates of HIV-1 with thymic and tonsillar dendritic cells in vitro 

  Cameron, PU; Lowe, MG; Sotzik, F; Coughlan, AF; Crowe, SM; Shortman, K (ROCKEFELLER UNIV PRESS, 1996-04-01)

  Dendritic cells isolated from thymus and tonsil were tested for susceptibility to HIV-1 strains that are tropic for macrophages or for T cell lines. DCs were purified by cell sorting and before infection expressed high ...

• Comparison of Bone and Renal Effects In HIV-infected Adults Switching to Abacavir or Tenofovir Based Therapy in a Randomized Trial 

  Rasmussen, TA; Jensen, D; Tolstrup, M; Nielsen, US; Erlandsen, EJ; Birn, H; Ostergaard, L; Langdahl, BL; Laursen, AL (PUBLIC LIBRARY SCIENCE, 2012-03-29)

  INTRODUCTION: Our objective was to compare the bone and renal effects among HIV-infected patients randomized to abacavir or tenofovir-based combination anti-retroviral therapy. METHODS: In an open-label randomized trial, ...

• Administration of a Toll-Like Receptor 9 Agonist Decreases the Proviral Reservoir in Virologically Suppressed HIV-Infected Patients 

  Winckelmann, AA; Munk-Petersen, LV; Rasmussen, TA; Melchjorsen, J; Hjelholt, TJ; Montefiori, D; Ostergaard, L; Sogaard, OS; Tolstrup, M (PUBLIC LIBRARY SCIENCE, 2013-04-26)

  Toll-like receptor (TLR) agonists can reactivate HIV from latently infected cells in vitro. We aimed to investigate the TLR-9 agonist, CPG 7909's in vivo effect on the proviral HIV reservoir and HIV-specific immunity. This ...

View more